Compliance
-

OPINION: How can financial institutions drive efficiency in global regulatory reporting in 2026 and beyond?
This article explores how firms can move from crippling architectural stress to maximum efficiency by adopting standardized data models and supervised AI.
-

FDA seeks comments on expedited CNPV pilot program
The controversial Commissioner’s National Priorities Voucher program awards “ultra-fast” reviews for medications and biological products of strategic national importance while upholding the FDA’s standards.
-

The $4.4 trillion shadow economy
Nasdaq report warns of “industrialized” crime crisis that is significantly outpacing the legitimate global economy.
-

FTC Launches ‘integrated’ healthcare task force
The new Healthcare Task Force is the latest action in the commission’s move to advance healthcare enforcement as laid out in a 2025 executive order.
-

FCA guidance on non-financial misconduct: What firms need to know before September 2026
Firms should take steps now to identify and mitigate NFM-related risks, including improving culture (a key driver of good conduct).
-

ASIC roundup: Macquarie in court, trimmed regulation, plus more
The Australian Securities and Investments Commission’s latest actions and news, March 10-20, 2026.
-

Badly fitting risk – lessons from impact investment
When buying off-the-shelf guff policies leads to poor risk management: what to look out for and what to avoid.

